Cypralis' Grant - II Round

Cypralis raised a round of funding on March 01, 2017. Investors include Alzheimer's Drug Discovery Foundation.

Cypralis is a life sciences company engaged in the preclincial development of nonimmunosuppressive peptidyl-prolyl isomerase (PPIase) inhibitors for a range of potential therapeutic indications, inclu…

Articles about Cypralis' Grant - II Round: